Other
Aging
0
Pipeline Programs↗
9
Active Trials↗
1
Companies Involved↗
Aging is an early-stage landscape with 0 programs across 1 company. The most active players are Università degli Studi di Trento.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
37
clinical trials
Completed18 · 49%
Unknown status6 · 16%
Recruiting5 · 14%
Withdrawn3 · 8%
Not yet recruiting3 · 8%
Enrolling by invitation1 · 3%
Other1 · 3%
Clinical Trials
Trial Activity
37 trials
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older Adults
Not yet recruiting·FFlorida Institute for Human and Machine Cognition·Preclinical·NCT07572266·226 enrolled
Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)
Completed·TThe University of Texas Health Science Center at San Antonio·Phase 2·NCT02865499·8 enrolled
Sex, Aging and Antiretroviral Pharmacokinetics
Completed·—·N/A·NCT00666055·11 enrolled
Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of Aging
Completed·—·N/A·NCT00974480·120 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)